Bellevue Group AG

Q1 2023 13F-HR Holdings

Location
Kuesnacht, V8
Holdings as of
3/31/2023
Date filed
5/15/2023
Form type
13F-HR
Num holdings
159
Total value ($000)
$6,891,167
Net value change ($000)
-643,458 (-8.5%)
New positions
7
Sold out positions
19
Turnover %
3.2%
Sector allocation + QoQ delta (equities-only)

Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown

Prev filing: 2/14/2023 Next filing: 8/14/2023 SEC filing

Snapshot: Change Analysis

Compared to Q4 2022
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
MDT 51,037 106.2%
VRTX 44,463 14.0%
ALGN 40,483 242.4%
Accolade, Inc. 29,475 102.9%
PACB 28,364 53.5%
VEEV 18,276 60.8%
EXAS 18,112 27.9%
SYK 18,042 15.0%
Sage Therapeutics, Inc. 16,408 14.5%
PEN 16,141 32.1%
Top Reduces (Value $000, Stocks/ETFs)
Myovant Sciences Ltd. -159,351 -100.0%
NBIX -66,724 -20.1%
MRNA -45,907 -16.2%
ALNY -41,993 -19.2%
CI -38,892 -74.0%
JAZZ -37,153 -30.8%
ELV -33,899 -44.2%
INCY -32,221 -13.6%
IONS -28,072 -7.6%
UNH -26,850 -22.6%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type